New York, NY, United States of America

Rasa Zarnegar

This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Cornell University. Active years: 2015-2026.

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 57(Granted Patents)


Company Filing History:


Years Active: 2015-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Rasa Zarnegar: Innovator in Thyroid Evaluation Technologies

Introduction

Rasa Zarnegar is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of medical diagnostics, particularly in evaluating thyroid test samples. With a total of 3 patents, her work has the potential to impact patient care and treatment decisions.

Latest Patents

Rasa Zarnegar's latest patents focus on the critical task of distinguishing between benign and malignant indeterminate thyroid lesions. The application describes methods for accurately evaluating whether thyroid test samples, especially indeterminate thyroid samples, are benign or malignant. This innovation is crucial for improving diagnostic accuracy and patient outcomes.

Career Highlights

Throughout her career, Rasa has worked with esteemed institutions such as Cornell University and Parker-Hannifin Corporation. Her experience in these organizations has allowed her to develop and refine her innovative approaches to thyroid evaluation.

Collaborations

Rasa has collaborated with notable professionals in her field, including Xavier M. Keutgen and Thomas J. Fahey III. These partnerships have contributed to her research and the advancement of her patented technologies.

Conclusion

Rasa Zarnegar's work in thyroid evaluation technologies exemplifies the impact of innovation in the medical field. Her patents and collaborations highlight her commitment to improving diagnostic methods and patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…